# Glaukos Corporation – FDA Inspection, Apr 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/glaukos-corporation/1b4713bf-a869-4279-8c47-8e76dc9f26ea
Source feed: FDA_Inspections

> FDA inspection 1267669 of Glaukos Corporation, April 22, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267669
- Company Name: Glaukos Corporation
- Inspection Date: 2025-04-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1251714 - 2024-08-15
- FDA Inspection 1211136 - 2023-07-19
- FDA Inspection 1068254 - 2018-08-03
- FDA Inspection 981961 - 2016-06-10
- FDA Inspection 835427 - 2013-06-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)
- [Youkeun Kim](https://www.keypedia.com/people/youkeun-kim/94ccfde4-72f7-4df1-9c68-ede73e5e23d0)

Company: https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b